僅用于工業應用或科學研究，不可用于人類或動物的臨床診斷或治療，非藥用. Emactuzumab（RG 7155） is a specific monoclonal antibody that inhibits colonystimulating factor 1 receptor （CSF1R） activation. Emactuzumab has high affinity for CSF-1R with Ki value of 0.2 nM to blocks CSF-1R dimerization. Emactuzumab can be used for the research of several diseases, such as diffuse-type tenosynovial giant cell tumour （dt-GCT）